Published in Int J Mol Med on August 04, 2016
Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol (2006) 3.44
Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2011) 3.06
Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem (1999) 2.13
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. Proc Natl Acad Sci U S A (2008) 1.80
Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol (2003) 1.76
TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol (2009) 1.61
The Immune Response to Skin Trauma Is Dependent on the Etiology of Injury in a Mouse Model of Burn and Excision. J Invest Dermatol (2015) 1.50
TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol (2013) 1.47
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging (2011) 1.46
Cytokine expression in the alkali-burned cornea. Curr Eye Res (1997) 1.35
PPARs in diseases: control mechanisms of inflammation. Curr Med Chem (2005) 1.33
A review of the local pathophysiologic bases of burn wound progression. J Burn Care Res (2010) 1.22
Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol (2005) 1.21
Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice. Am J Physiol Cell Physiol (2007) 1.16
The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol (2010) 1.10
An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell Mol Life Sci (1999) 1.07
Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. Invest Ophthalmol Vis Sci (2013) 1.05
Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea. Ocul Immunol Inflamm (1997) 1.04
Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. J Trauma (2006) 1.00
Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res (2003) 0.98
Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. Exp Eye Res (2005) 0.97
Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J Hepatol (2007) 0.97
Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int J Obes Relat Metab Disord (2003) 0.97
Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist. Invest Ophthalmol Vis Sci (2009) 0.97
Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea (2012) 0.96
Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth. BMC Med Genomics (2009) 0.95
Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. Mol Vis (2010) 0.93
Inhibition of RAP1 enhances corneal recovery following alkali injury. Invest Ophthalmol Vis Sci (2015) 0.91
Pretranscriptional regulation of Tgf-beta1 by PI polyamide prevents scarring and accelerates wound healing of the cornea after exposure to alkali. Mol Ther (2009) 0.91
Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model. Mol Pharm (2012) 0.90
Antifibrotic effect by activation of peroxisome proliferator-activated receptor-gamma in corneal fibroblasts. Mol Vis (2009) 0.90
Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. Curr Eye Res (2014) 0.89
Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells. Matrix Biol (2016) 0.88
Early and late complications of ocular burn injuries. J Plast Reconstr Aesthet Surg (2014) 0.88
Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns (2007) 0.87
Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. Invest Ophthalmol Vis Sci (2002) 0.87
Perturbed mononuclear phagocyte system in severely burned and septic patients. Shock (2013) 0.86
Suberoylanilide hydroxamic acid (vorinostat): its role on equine corneal fibrosis and matrix metalloproteinase activity. Vet Ophthalmol (2014) 0.86
PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies. PPAR Res (2008) 0.86
PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines. Mucosal Immunol (2015) 0.86
Burn enhances toll-like receptor induced responses by circulating leukocytes. Int J Clin Exp Med (2012) 0.86
Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing. Jpn J Ophthalmol (2008) 0.86
Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization. Exp Eye Res (2014) 0.85
Expression of matrix metalloproteinases (MMP)-12 by myofibroblasts during alkali-burned corneal wound healing. Curr Eye Res (2009) 0.85
Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. Invest Ophthalmol Vis Sci (2013) 0.84
Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS One (2012) 0.84
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemother Pharmacol (2005) 0.84
G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol (2014) 0.83
Differential Effects of Dexamethasone and Doxycycline on Inflammation and MMP Production in Murine Alkali-Burned Corneas Associated with Dry Eye. Ocul Surf (2016) 0.83
Role of senescent fibroblasts on alkali-induced corneal neovascularization. J Cell Physiol (2012) 0.83
Effects of the matrix metalloproteinase inhibitor GM6001 on the destruction and alteration of epithelial basement membrane during the healing of post-alkali burn in rabbit cornea. Jpn J Ophthalmol (2006) 0.83
An inhibitor of the matrix metalloproteinase synthesized by rabbit corneal epithelium. Invest Ophthalmol Vis Sci (1991) 0.83
Activated skin γδ T-cells regulate T-cell infiltration of the wound site after burn. Innate Immun (2014) 0.83
MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ. Mod Rheumatol (2015) 0.83
Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci (2008) 0.82
Protein phosphatase magnesium dependent 1A governs the wound healing-inflammation-angiogenesis cross talk on injury. Am J Pathol (2014) 0.82
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation. Exp Neurol (2015) 0.82
Macrophage PPARγ and impaired wound healing in type 2 diabetes. J Pathol (2015) 0.82
Rosiglitazone, a PPAR-gamma ligand, reduces burn progression in rats. J Burn Care Res (2009) 0.82
Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul Surf (2015) 0.81
Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy. Eur J Clin Microbiol Infect Dis (2010) 0.81
Functional genomics of PPAR-gamma in human immunomodulatory cells. Mol Cell Biochem (2006) 0.81
Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea. Curr Eye Res (2013) 0.81
Astragalin inhibits IL-1β-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-κB and MAPK activation. Int Immunopharmacol (2015) 0.81
Physical and chemical injuries to eyes and eyelids. Clin Dermatol (2015) 0.81
Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis. Mol Med Rep (2014) 0.80
An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model. Mol Vis (2013) 0.80
A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction. Stem Cells Transl Med (2015) 0.80
PPAR-γ agonist pioglitazone affects rat gouty arthritis by regulating cytokines. Genet Mol Res (2014) 0.80
β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology (2014) 0.80
Protective effect of soft contact lenses after Boston keratoprosthesis. Br J Ophthalmol (2015) 0.80
Effects of topical chondrocyte-derived extracellular matrix treatment on corneal wound healing, following an alkali burn injury. Mol Med Rep (2014) 0.79
PPAR-γ activation by Tityus serrulatus venom regulates lipid body formation and lipid mediator production. Toxicon (2014) 0.79
Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats. CNS Neurosci Ther (2015) 0.79
A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis. J Biol Chem (2015) 0.79
Diospyros kaki Extract Inhibits Alkali Burn-Induced Corneal Neovascularization. J Med Food (2015) 0.79
Macrophage polarization: the link between inflammation and related diseases. Inflamm Res (2016) 0.79
Successful management of severe unilateral chemical burns in children using simple limbal epithelial transplantation (SLET). Br J Ophthalmol (2015) 0.79
Pseudolaric acid B inhibits T-cell mediated immune response in vivo via p38MAPK signal cascades and PPARγ activation. Life Sci (2014) 0.79
[Split-cornea transplantation - a novel concept to reduce corneal donor shortage]. Klin Monbl Augenheilkd (2012) 0.79
[Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency]. Ophthalmologe (2016) 0.78
Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmol (2014) 0.78
Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats. Invest Ophthalmol Vis Sci (2015) 0.78
NK1 receptor antagonists as a new treatment for corneal neovascularization. Invest Ophthalmol Vis Sci (2014) 0.78
Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice. Int Immunopharmacol (2014) 0.78
Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture. Stroke (2015) 0.78
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. Invest Ophthalmol Vis Sci (2013) 0.78
Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-γ Expression. PLoS One (2015) 0.78
Regulation of peroxisome proliferator-activated receptor β/δ expression and activity levels by toll-like receptor agonists and MAP kinase inhibitors in rat astrocytes. J Neurochem (2014) 0.78
Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway. Int J Mol Med (2014) 0.78
Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists. J Neurochem (2015) 0.78
Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases. J Ophthalmol (2015) 0.78
Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases. Br J Ophthalmol (2014) 0.78
Corneal blindness and xenotransplantation. Xenotransplantation (2014) 0.78
Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. Int J Mol Med (2014) 0.78
KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization. Ophthalmic Res (2013) 0.78
Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: the effect on Toll-like receptor signaling pathways. Pancreas (2013) 0.77
PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-γ to increase surface FasL. Apoptosis (2016) 0.77
Skin dendritic cells in burn patients. Ann Burns Fire Disasters (2009) 0.77